We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.34B
AUM Growth
+$167M
Cap. Flow
+$109M
Cap. Flow %
8.11%
Top 10 Hldgs %
5.95%
Holding
1,390
New
385
Increased
344
Reduced
326
Closed
334

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$10M
2
WDAY icon
Workday
WDAY
+$8.36M
3
EG icon
Everest Group
EG
+$7.66M
4
ICE icon
Intercontinental Exchange
ICE
+$6.67M
5
APH icon
Amphenol
APH
+$6.54M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$9.98M
2
COST icon
Costco
COST
+$9.67M
3
TRMB icon
Trimble
TRMB
+$9.42M
4
KR icon
Kroger
KR
+$8.99M
5
LLY icon
Eli Lilly
LLY
+$8.14M

Sector Composition

Rank Sector Weight
1 Financials 17.56%
2 Consumer Discretionary 14.61%
3 Healthcare 13.6%
4 Industrials 13.3%
5 Technology 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSC icon
1076
American Superconductor
AMSC
$1.53B
-12,408
Closed -$290K
ANF icon
1077
Abercrombie & Fitch
ANF
$4.84B
-4,994
Closed -$888K
ARCO icon
1078
Arcos Dorados Holdings
ARCO
$1.71B
-115,363
Closed -$1.04M
ARVN icon
1079
Arvinas
ARVN
$589M
-48,271
Closed -$1.28M
ATI icon
1080
ATI
ATI
$30.9B
-6,294
Closed -$349K
ATNM icon
1081
Actinium Pharmaceuticals
ATNM
$30.2M
-32,034
Closed -$237K
ATR icon
1082
AptarGroup
ATR
$8.43B
-5,433
Closed -$765K
AUPH icon
1083
Aurinia Pharmaceuticals
AUPH
$2.02B
-19,597
Closed -$112K
AVGO icon
1084
Broadcom
AVGO
$1.99T
-15,690
Closed -$2.52M
AVNS
1085
DELISTED
Avanos Medical
AVNS
-18,004
Closed -$359K
AXP icon
1086
American Express
AXP
$232B
-1,068
Closed -$247K
BABA icon
1087
Alibaba
BABA
$293B
-5,663
Closed -$408K
BAH icon
1088
Booz Allen Hamilton
BAH
$9.43B
-2,980
Closed -$459K
BAP icon
1089
Credicorp
BAP
$29.8B
-7,011
Closed -$1.13M
BBCP icon
1090
Concrete Pumping Holdings
BBCP
$475M
-15,116
Closed -$90.8K
BCO icon
1091
Brink's
BCO
$4.72B
-3,204
Closed -$328K
BEKE icon
1092
KE Holdings
BEKE
$18.7B
-25,596
Closed -$362K
BHE icon
1093
Benchmark Electronics
BHE
$2.89B
-12,692
Closed -$501K
BHP icon
1094
BHP
BHP
$222B
-10,270
Closed -$586K
BILL icon
1095
BILL Holdings
BILL
$5.11B
-5,156
Closed -$271K
BLDR icon
1096
Builders FirstSource
BLDR
$7.91B
-30,749
Closed -$4.26M
BLMN icon
1097
Bloomin' Brands
BLMN
$924M
-189,280
Closed -$3.64M
BMO icon
1098
Bank of Montreal
BMO
$129B
-14,090
Closed -$1.18M
BMRN icon
1099
BioMarin Pharmaceuticals
BMRN
$13.3B
-13,186
Closed -$1.09M
BN icon
1100
Brookfield
BN
$111B
-7,457
Closed -$206K

Similar funds

Campbell & Co Investment Adviser's Q3 2024 Portfolio in Review

As of Q3 2024, Campbell & Co Investment Adviser held 1,390 positions worth $1.34B, up 14% from $1.18B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $109M of net new capital in Q3 2024, opening 385 new positions and adding to 344 existing holdings. Its largest new stake was PepsiCo: 58,494 shares worth $9.95M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Global Payments, an estimated $9.98M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2024 buy was PepsiCo: 58,494 shares worth $9.95M.
  • Campbell & Co Investment Adviser added most to Workday in Q3 2024, an estimated $8.36M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2024 reduction was Global Payments, cutting an estimated $9.98M.
  • Campbell & Co Investment Adviser fully exited Costco in Q3 2024, selling an estimated $9.67M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.34B portfolio in Q3 2024.
  • Campbell & Co Investment Adviser opened 385 new positions and closed 334 in Q3 2024.
  • Campbell & Co Investment Adviser's portfolio value rose 14% quarter-over-quarter to $1.34B.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2024, filed 12 Nov 2024.